Home / See, Read & Share / Federation News

Nikki & Michael Simkins

Nikki Simkins is CEO of E11EVEN Vodka. As the visionary behind the brand, Nikki has worked endlessly to create a product that embodies the spirit of Miami. She has spearheaded the effort to propel this brand into success and put together a superstar team to make it happen.

Michael Simkins is an owner of E11EVEN Partners, the company behind the high-profile E11EVEN Miami nightclub, hotel, condominium, Vodka, crypto and sound equipment, and has helped guide the company's evolution from a hospitality firm to a lifestyle brand. He is also President & CEO, Lion Development Group.

The Simkins family, with deep South Florida roots that span decades, is highly respected for supporting collaborative, community-based projects that drive sustainable economic growth and bring global visibility to the region.

The family and Mr. Simkins are involved with various local philanthropic initiatives.

Diller Teen Fellows Visit Yerucham

Diller Teen Fellows Visit Yerucham

The group of arrived in Federation’s Israeli partner city on for Community Week with 18 of their Yerucham teen peers.

Read More

Don’t Miss Milk & Honey: Sunday, August 23

Don’t Miss Milk & Honey: Sunday, August 23

Register today for this highly popular, family-friendly volunteer opportunity organized by Jewish Community Services of South Florida in partnership with Federation.

Read More

Three Grant Opportunities Now Available

Three Grant Opportunities Now Available

Applications are now being accepted by the Greater Miami Jewish Federation for three 2025 grant opportunities: Women’s Impact Initiative Grants, Jewish Incubator Grants and Israel Engagement & Education Grants.

Read More

July Is Disability Pride Month

July Is Disability Pride Month

July is Disability Pride Month and Federation’s Miami Jewish Abilities Alliance works year-round to celebrate and support Jewish Miamians living with disabilities.

Read More

Stay in Touch

Receive news about Greater Miami Jewish Federation events and more.